Tellus is a leading provider of mobile care delivery, Electronic Visit Verification (eVV) and claims processing technology designed especially for the Home Health and Long-Term Care Markets. Tellus is proud to be the provider of choice among a variety of states, managed care organizations and provider agencies. Our comprehensive, cloud-based solutions work to simplify, streamline and quickly and easily verify care delivery tasks and process claim data right at the point of care. That means agencies, caregivers and patients can focus their time and attention on what matters most — improved care delivery with better outcomes, greater efficiency and cost reduction.
Bradley LevinePresident & CEO
Lia SweeneyStrategic Innnovation Officer & CFO
Chris PernicanoChief Operating Officer
Joe SchnurChief Customer Officer
Vicki TimineyVice President, Marketing & Customer Engagement
Brad has enjoyed a successful career building and selling software companies. Prior to Tellus, Brad launched and scaled the second largest life and annuity insurance processor in the country and maintains a seat on the board as a main shareholder. His entrepreneurial commitment to building solutions for the Healthcare and Government industries led him to launch Tellus in 2013.
Lia began her career as a Certified Public Accountant working with KPMG. She is an accomplished professional with diverse functional and industry experience with companies ranging in size from Fortune 500 to start-up. Lia earned her B.S. and M.S. in Accounting from the University of Florida and her M.S. in Management Information Systems from Nova Southeastern University.
Chris has more than 20 years of experience in the FinTech space across all aspects of small and medium company operation. In 1996, Pernicano co-founded his first startup, and by 2000, he had co-founded his second, a SaaS-based technology startup that would eventually become the second largest of its kind in the country. In 2017, Pernicano transitioned to Tellus in the COO role.
Joe is an experienced executive leader and innovative problem-solver. Prior to joining Tellus, Joe spent nearly 20 years leading both growth and new business endeavors for GE Healthcare. There, he successfully built and led a national team of commercial leaders that drove business development for GE Healthcare’s largest global client, booking revenue in excess of $400M per year.
Vicki has over 25 years of experience leading marketing and customer communications for marquee consumer and b2b brands in Telecom, Financial Services and Healthcare IT. She’s built and launched successful go-to-market initiatives as well as created and executed in-market programs that increased revenue and drove brand loyalty. She holds a B.A. in Journalism and earned an M.A. in Communication Studies at the University of Kansas.
Jeffrey L. Strauss
Jeffrey is a healthcare finance and operations executive whose career spans more than 30 years. A recognized revenue cycle subject matter expert, Jeffrey advises clients in many health care industry organizations including academic medical centers, post-acute providers, physician group practices and Commercial, Medicare and Medicaid health plans. Additionally, Jeffrey has worked with large managed care service organizations, start-up technology firms and health care IT system vendors. He’s a strategic thinker who has written point-of-view documents on ICD-10 and the Affordable Care Act; and has spoken at the HFMA, AHIMA and AHIA conferences on revenue cycle improvement and project risk management.
Jason J. Rosenberg
Dr. Rosenberg is a partner and shareholder of the Orthopaedic Institute (TOI), a high-volume multi-specialty medical enterprise consisting of more than 300 employees, full service diagnostics and outpatient surgery centers. He has served on the Plastic Surgery faculty at the University of Florida where he has engaged in teaching, research and patient care. A published author and accomplished speaker, Dr. Rosenberg has served on scientific advisory boards and as a consultant to a number of privately held and publicly traded companies. He is a former Lieutenant Colonel in the United States Air Force Reserve Medical Corps.
Denis J. Muskat
Denis has been in the healthcare space for more than 40 years and has provided financial leadership to publicly traded corporations as well as to companies in the private sector. After an initiation in public accounting, Denis started his career at a Fortune 500 healthcare organization that provided products and services to hospitals globally. He was a pioneer in the start-up of a mail order prescription service business that was spun off and ultimately developed into a Fortune 500 pharmaceutical services provider. He has served as CFO of large organizations and has been on the Board of Directors of a multi-million-dollar health and pension trust as well as Director of an insurance company. Denis was credentialed as a CPA and remains active with the American Institute of Certified Public Accountants and the Utah Association of CPAs.
Saul has spent more than 30 years in the healthcare arena with a primary focus in the Pharmaceutical sector. After receiving his Pharmacy degree from Northeastern University, he held multiple senior level positions at PCS Healthcare, Eli Lilly and Company, RxAmerica, and most recently at McKesson Corporation. Saul is well versed in both manufacturings as well as commercialization and access for pharmaceuticals. Saul also holds an MBA from the University of New Haven.
Currently serving as CEO and ISO of Pharmacy Stars, Keith uses his 17 years of experience designing, building and delivering high-availability, HIPAA-compliant SaaS solutions for health systems and health plans. One out of three hospitals in the US use these solutions that span formulary management, USP 797 compliance, pediatric dosing, enterprisewide clinical surveillance, medication reconciliation, clinical workforce optimization, drug cost optimization and 340B compliance. Keith has founded or co-founded six companies, which collectively have generated in excess of $200 Million in subscription-based revenue and generated investor returns of 4x – 10x their investments.